1.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 75 Sponsor: Other Protocol IDs: WJTOG0101, NCT00139971
|
|
2.
|
Phase: Phase III Type: Treatment Status: Active Age: Over 18 Sponsor: Other Protocol IDs: AERO-MB02, NCT00189631
|
|
3.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 79 Sponsor: Other Protocol IDs: ICOG-CC01, NCT00497107
|
|
4.
|
Phase: Phase III Type: Treatment Status: Active Age: 20 to 80 Sponsor: Other Protocol IDs: EMBARK, NCT01082510
|
|
5.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: FEMH-94037, NCT00384800
|
|
6.
|
Phase: Phase II Type: Treatment Status: Active Age: 70 and over Sponsor: Other Protocol IDs: UUH-ONC-0019, NCT00625352
|
|
7.
|
Phase: Phase II Type: Treatment Status: Active Age: 20 and over Sponsor: Other Protocol IDs: 376, NCT00855881
|
|
8.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 to 80 Sponsor: Other Protocol IDs: HR-97-035, NCT00890188
|
|
9.
|
Phase: Phase II Type: Treatment Status: Active Age: 19 to 79 Sponsor: Other Protocol IDs: T2207, NCT00931203
|
|
10.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 3065, NCT01050426
|
|
11.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: CRC-SNU-2011-01, NCT01409005
|
|
12.
|
Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: ESLC1 (SADAT study), NCT01539018
|